€86.80
0.00%
Xetra, Sep 18, 05:35 pm CEST. Closed.
ISIN
DE000A40QVM8
Symbol
1INN
Industry

innoscripta Target price 2026 - Analyst rating & recommendation

innoscripta Classifications & Recommendation

Buy
88%
Hold
13%

innoscripta Price Target

Target Price €216.75
Price €86.80
Potential
Number of Estimates 4
4 Analysts have issued a price target innoscripta 2027 . The average innoscripta target price is €216.75. This is higher than the current stock price. The highest price target is
€236.25 172.18%
register free of charge
, the lowest is
€202.00 132.72%
register free of charge
.
A rating was issued by 8 analysts: 7 Analysts recommend innoscripta to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the innoscripta stock has an average upside potential 2027 of . Most analysts recommend the innoscripta stock at Purchase.

Sales and Margin forecast 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Revenue Million € 103.41 149.79
59.81% 44.85%
EBITDA Margin 61.58% 57.37%
6.23% 6.84%
Net Margin 41.20% 38.03%
6.27% 7.71%

4 Analysts have issued a sales forecast innoscripta 2026 . The average innoscripta sales estimate is

€150m
unlock
. This is
50.39% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
€155m 56.02%
unlock
, the lowest is
€143m 43.36%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 €103m 59.81%
2026
€150m 44.85%
unlock
2027
€199m 32.65%
unlock
2028
€243m 22.22%
unlock

4 Analysts have issued an innoscripta EBITDA forecast 2026. The average innoscripta EBITDA estimate is

€85.9m
unlock
. This is
28.11% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
€90.3m 34.62%
unlock
, the lowest is
€80.9m 20.53%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 €63.7m 69.77%
2026
€85.9m 34.95%
unlock
2027
€114m 32.11%
unlock
2028
€135m 19.04%
unlock

EBITDA Margin

2025 61.58% 6.23%
2026
57.37% 6.84%
unlock
2027
57.14% 0.40%
unlock
2028
55.65% 2.61%
unlock

4 innoscripta Analysts have issued a net profit forecast 2026. The average innoscripta net profit estimate is

€57.0m
unlock
. This is
26.60% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
€59.5m 32.31%
unlock
, the lowest is
€53.9m 19.78%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 €42.6m 69.83%
2026
€57.0m 33.70%
unlock
2027
€75.2m 32.05%
unlock
2028
€89.3m 18.70%
unlock

Net Margin

2025 41.20% 6.27%
2026
38.03% 7.71%
unlock
2027
37.86% 0.45%
unlock
2028
36.77% 2.88%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Earnings Per Share 4.26 5.70
69.72% 33.80%
P/E 15.24
EV/Sales 5.18

4 Analysts have issued a innoscripta forecast for earnings per share. The average innoscripta EPS is

€5.70
unlock
. This is
26.67% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
€5.95 32.22%
unlock
, the lowest is
€5.39 19.78%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 €4.26 69.72%
2026
€5.70 33.80%
unlock
2027
€7.52 31.93%
unlock
2028
€8.93 18.75%
unlock

P/E ratio

Current
2026
15.24 20.99%
unlock
2027
11.54 24.28%
unlock
2028
9.72 15.77%
unlock

Based on analysts' sales estimates for 2026, the innoscripta stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 7.78
2026
5.18 33.48%
unlock
2027
3.90 24.62%
unlock
2028
3.19 18.18%
unlock

P/S ratio

Current
2026
5.55 33.51%
unlock
2027
4.19 24.61%
unlock
2028
3.43 18.18%
unlock

Current innoscripta Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
BERENBERG
Locked
Locked
Locked Jun 02 2026
WARBURG RESEARCH GMBH
Locked
Locked
Locked May 28 2026
Analyst Rating Date
Locked
BERENBERG:
Locked
Locked
Jun 02 2026
Locked
WARBURG RESEARCH GMBH:
Locked
Locked
May 28 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today